INCOME STATEMENT (Quarterly GAAP In millions $) |
(Dec 31 2024) Q4 2024 |
(Sep 30 2024) Q3 2024 |
(Jun 30 2024) Q2 2024 |
(Mar 31 2024) Q1 2024 |
(Dec 31 2023) Q4 2023 |
Revenue From Contract With Customer Excluding Assessed Tax |
|
125.84 |
110.59 |
95.24 |
|
Other Revenue |
|
-0.42 |
-0.40 |
-0.48 |
|
Total Revenue |
145.17 |
125.42 |
110.19 |
94.76 |
106.54 |
Cost of Goods and Services Sold |
102.00 |
89.00 |
75.00 |
69.00 |
79.00 |
Gross
Profit |
43.17 |
36.42 |
35.19 |
25.76 |
27.54 |
Selling, Administration, Marketing |
12.37 |
10.96 |
4.52 |
9.53 |
9.34 |
Depriciation & Amortization |
0.36 |
0.37 |
0.37 |
0.37 |
0.44 |
Research and Development Expense |
5.25 |
4.65 |
4.96 |
5.20 |
5.43 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
0.00 |
0.00 |
- |
- |
- |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
119.98 |
104.97 |
84.84 |
84.09 |
94.20 |
Operating income/-loss
|
25.19 |
20.45 |
25.34 |
10.66 |
12.33 |
Other Deductions / - Income |
Interest expense |
3.35 |
- |
- |
3.35 |
3.60 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
3.35 |
- |
- |
3.35 |
3.60 |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-1.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Interest Expense Nonoperating |
- |
2.84 |
2.91 |
- |
- |
Total costs & expenses |
122.33 |
107.81 |
87.75 |
87.44 |
97.80 |
Income /-loss before income taxes |
22.84 |
17.61 |
22.44 |
7.32 |
8.74 |
Income taxes expenses/-benefit |
-0.45 |
0.28 |
0.90 |
0.20 |
0.37 |
Income after income taxes |
23.29 |
17.34 |
21.54 |
7.12 |
8.37 |
Net income/-loss
of other equity |
- |
- |
- |
- |
0.00 |
Income/-loss
from cont. Ops. |
23.29 |
17.34 |
21.54 |
7.12 |
8.37 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
23.29 |
17.34 |
21.54 |
7.12 |
8.37 |
Non-controlling interests |
- |
- |
- |
- |
- |
Preferred dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
23.29 |
17.34 |
21.54 |
7.12 |
8.37 |
EBIT |
26.18 |
17.61 |
22.44 |
10.66 |
12.33 |
EBITD |
27.09 |
18.55 |
23.39 |
11.61 |
13.26 |
EBITDA |
27.62 |
18.99 |
23.78 |
12.22 |
13.95 |